Cellectar Biosciences, Inc. Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
Cellectar Biosciences, Inc. (CLRB) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 48.27 thousand shares for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-12.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2016-05-12
- Cellectar Biosciences, Inc. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2016-03-31 was 48.27K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month |
|---|---|
| 2016-03-31 | 48.27K shares 10-Q · filed 2016-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |